About Scentian Bio:
Scentian Bio: is a company based in Auckland (New Zealand) founded in 2020 by Andrew Kralicek and Jonathan Good. Scentian Bio: has raised $10.1 million across 4 funding rounds from investors including OurCrowd, Gates Foundation and Fonterra. Scentian Bio: offers products and services including Real-time Sensors and Insect Receptor Technology. Scentian Bio: operates in a competitive market with competitors including Noze, Canaery, Yesse Technologies, NanoScent and SmartNanotubes Technologies, among others.
- Headquarter Auckland, New Zealand
- Founders Andrew Kralicek, Jonathan Good
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Scentian Bio Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.1 M (USD)
in 4 rounds
-
Latest Funding Round
$7 M (USD), Seed
Apr 07, 2026
-
Investors
OurCrowd
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Scentian Bio:
Scentian Bio: offers a comprehensive portfolio of products and services, including Real-time Sensors and Insect Receptor Technology.
Detects chemical signals for health and environmental monitoring applications
Utilizes insect receptors to interpret volatile compounds in real time
Funding Insights of Scentian Bio:
Scentian Bio: has successfully raised a total of $10.1M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $7 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Scentian Bio:
Scentian Bio: has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include OurCrowd, Gates Foundation and Fonterra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital firm and infrastructure firm investing in multiple sectors
|
Locked | Locked | Locked | |
|
PE fund focused on high growth companies of New Zealand
|
Locked | Locked | Locked |
Investor details for Scentian Bio:
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scentian Bio:
Investment portfolio details for Scentian Bio:
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scentian Bio:
Detailed financials for Scentian Bio:
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scentian Bio: Comparisons
Peer comparison for Scentian Bio:
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scentian Bio:
Scentian Bio: operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Noze, Canaery, Yesse Technologies, NanoScent and SmartNanotubes Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of AI-based platform for air-borne disease detection
|
|
| Locked | Locked | Locked |
Nose-computer interfaces are developed to digitize the sense of smell.
|
|
| Locked | Locked | Locked |
Nanochip-based olfactory systems are developed for odor detection.
|
|
| Locked | Locked | Locked |
Provider of air and scent quality control solutions for cars and utilities
|
|
| Locked | Locked | Locked |
Manufacturer of smell detector chips for diverse applications and IoT solutions
|
Detailed competitors of Scentian Bio:
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scentian Bio:
Complete news archive for Scentian Bio:
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scentian Bio:
Scentian Bio: was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Scentian Bio: is headquartered in Auckland, New Zealand.
Jonathan Good is the current CEO of Scentian Bio:. They have also founded this company.
Scentian Bio: is a funded company, having raised a total of $10.1M across 4 funding rounds to date.
Scentian Bio was founded in 2020 in Auckland, New Zealand. Biosensor devices based on insect odorant receptors are developed for commercial applications in the medical and food industries. A machine learning-based biosensing platform is offered to detect volatile organic compounds, such as off-notes in food and beverages, fraud and adulterants in raw materials, while also enabling new product creation and providing objective assessments of flavors and fragrances.
Scentian Bio:'s top competitors include Canaery, Noze and Yesse Technologies.
Scentian Bio: offers Real-time Sensors and Insect Receptor Technology.
Scentian Bio: has 11 investors. Key investors include OurCrowd, Gates Foundation, Fonterra, Sprout Agritech, and Callaghan Innovation.